Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Drug Delivery Systems | 6 | 2023 | 2211 | 0.860 |
Why?
|
Microwaves | 1 | 2024 | 185 | 0.830 |
Why?
|
Lenses | 1 | 2022 | 42 | 0.820 |
Why?
|
Ablation Techniques | 1 | 2024 | 247 | 0.740 |
Why?
|
Lens, Crystalline | 1 | 2022 | 388 | 0.700 |
Why?
|
Microtechnology | 1 | 2019 | 70 | 0.650 |
Why?
|
Antineoplastic Agents | 9 | 2023 | 13597 | 0.630 |
Why?
|
Prostheses and Implants | 3 | 2021 | 1269 | 0.610 |
Why?
|
Neoplasms, Experimental | 3 | 2021 | 1228 | 0.590 |
Why?
|
Spectrum Analysis, Raman | 1 | 2018 | 237 | 0.540 |
Why?
|
Phantoms, Imaging | 2 | 2021 | 2509 | 0.470 |
Why?
|
Imaging, Three-Dimensional | 2 | 2024 | 4046 | 0.440 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2016 | 714 | 0.440 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1087 | 0.440 |
Why?
|
Cell Line, Tumor | 17 | 2024 | 16881 | 0.400 |
Why?
|
Surgery, Computer-Assisted | 1 | 2019 | 1003 | 0.380 |
Why?
|
Carcinoma | 1 | 2023 | 2330 | 0.380 |
Why?
|
Cerebellar Neoplasms | 1 | 2016 | 586 | 0.370 |
Why?
|
Medulloblastoma | 1 | 2016 | 678 | 0.370 |
Why?
|
Apoptosis | 5 | 2022 | 9466 | 0.360 |
Why?
|
Drug Monitoring | 1 | 2015 | 960 | 0.320 |
Why?
|
Melanoma | 2 | 2018 | 5689 | 0.310 |
Why?
|
Glioma | 1 | 2023 | 3417 | 0.310 |
Why?
|
Glioblastoma | 1 | 2023 | 3480 | 0.310 |
Why?
|
Mice, Nude | 4 | 2018 | 3600 | 0.290 |
Why?
|
Neoplasms | 7 | 2022 | 21986 | 0.290 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 2052 | 0.260 |
Why?
|
Cytoskeleton | 1 | 2010 | 1167 | 0.250 |
Why?
|
Actins | 2 | 2016 | 2048 | 0.230 |
Why?
|
Protein Kinase Inhibitors | 3 | 2018 | 5638 | 0.230 |
Why?
|
Animals | 20 | 2024 | 167718 | 0.220 |
Why?
|
Mice | 16 | 2024 | 81066 | 0.220 |
Why?
|
Endoscopy | 2 | 2024 | 1832 | 0.220 |
Why?
|
Pregnancy Outcome | 6 | 1993 | 2904 | 0.210 |
Why?
|
Neuropilin-1 | 1 | 2023 | 90 | 0.210 |
Why?
|
Doxorubicin | 3 | 2018 | 2211 | 0.200 |
Why?
|
Nitroquinolines | 1 | 2020 | 4 | 0.190 |
Why?
|
Galectin 3 | 1 | 2023 | 240 | 0.180 |
Why?
|
Tumor Microenvironment | 4 | 2023 | 3839 | 0.180 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2020 | 5253 | 0.170 |
Why?
|
Enzyme Inhibitors | 3 | 2020 | 3709 | 0.170 |
Why?
|
Drug Synergism | 3 | 2020 | 1746 | 0.170 |
Why?
|
Chickens | 1 | 2021 | 858 | 0.170 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2023 | 1124 | 0.160 |
Why?
|
Intercalating Agents | 1 | 2018 | 33 | 0.160 |
Why?
|
Xenograft Model Antitumor Assays | 5 | 2020 | 3573 | 0.160 |
Why?
|
Photons | 1 | 2022 | 581 | 0.160 |
Why?
|
Nucleotidyltransferases | 1 | 2020 | 243 | 0.160 |
Why?
|
Metal Nanoparticles | 1 | 2022 | 397 | 0.150 |
Why?
|
Growth Inhibitors | 1 | 2019 | 378 | 0.150 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2016 | 507 | 0.150 |
Why?
|
South Australia | 6 | 1993 | 26 | 0.150 |
Why?
|
Genes, erbB-2 | 1 | 2018 | 162 | 0.150 |
Why?
|
Temperature | 1 | 2024 | 2217 | 0.140 |
Why?
|
Obstetric Labor Complications | 4 | 1992 | 236 | 0.140 |
Why?
|
Pinocytosis | 1 | 2016 | 62 | 0.140 |
Why?
|
Workflow | 1 | 2021 | 850 | 0.140 |
Why?
|
bcl-X Protein | 1 | 2018 | 410 | 0.140 |
Why?
|
Receptors, Androgen | 1 | 2023 | 1073 | 0.140 |
Why?
|
Caspase 3 | 1 | 2018 | 728 | 0.130 |
Why?
|
Apgar Score | 3 | 1991 | 126 | 0.130 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2017 | 1723 | 0.130 |
Why?
|
Karyopherins | 1 | 2016 | 132 | 0.130 |
Why?
|
Cerebral Palsy | 2 | 1990 | 472 | 0.120 |
Why?
|
Microfilament Proteins | 2 | 2016 | 1133 | 0.120 |
Why?
|
Swine | 1 | 2024 | 5891 | 0.110 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2017 | 642 | 0.110 |
Why?
|
Maternal Age | 3 | 1992 | 806 | 0.110 |
Why?
|
Serum Albumin | 1 | 2016 | 672 | 0.110 |
Why?
|
Pregnancy, High-Risk | 2 | 1991 | 119 | 0.110 |
Why?
|
Deoxycytidine | 1 | 2017 | 873 | 0.110 |
Why?
|
Breech Presentation | 1 | 1993 | 39 | 0.110 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2016 | 621 | 0.100 |
Why?
|
Breast Neoplasms | 3 | 2018 | 20992 | 0.100 |
Why?
|
Calibration | 1 | 2015 | 813 | 0.100 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2016 | 555 | 0.100 |
Why?
|
Small-Area Analysis | 1 | 1992 | 55 | 0.100 |
Why?
|
Humans | 34 | 2024 | 757566 | 0.100 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 856 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 1403 | 0.100 |
Why?
|
Pregnancy Complications | 5 | 1992 | 2940 | 0.090 |
Why?
|
Rare Diseases | 1 | 2016 | 618 | 0.090 |
Why?
|
Amino Acids | 1 | 2016 | 1712 | 0.090 |
Why?
|
Antibodies | 1 | 2018 | 2420 | 0.090 |
Why?
|
Protein Kinases | 1 | 2017 | 1608 | 0.090 |
Why?
|
Benzodiazepines | 1 | 2016 | 1130 | 0.090 |
Why?
|
Microscopy, Atomic Force | 1 | 2010 | 247 | 0.090 |
Why?
|
Pancreatic Neoplasms | 2 | 2017 | 5348 | 0.080 |
Why?
|
Polyethylene Glycols | 1 | 2015 | 1188 | 0.080 |
Why?
|
Cell Physiological Phenomena | 1 | 2010 | 150 | 0.080 |
Why?
|
Molecular Imaging | 1 | 2016 | 813 | 0.080 |
Why?
|
Paclitaxel | 1 | 2016 | 1731 | 0.080 |
Why?
|
Proto-Oncogene Proteins | 2 | 2019 | 4492 | 0.080 |
Why?
|
Elasticity | 1 | 2010 | 652 | 0.080 |
Why?
|
Liver | 1 | 2024 | 7502 | 0.080 |
Why?
|
Extracellular Matrix | 1 | 2016 | 1722 | 0.080 |
Why?
|
Polymers | 1 | 2015 | 1612 | 0.070 |
Why?
|
Indoles | 1 | 2016 | 1824 | 0.070 |
Why?
|
Parity | 1 | 1991 | 924 | 0.070 |
Why?
|
Cell Movement | 2 | 2016 | 5196 | 0.070 |
Why?
|
Pyrimidines | 1 | 2019 | 3005 | 0.070 |
Why?
|
Gene Expression | 2 | 2016 | 7584 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2016 | 2859 | 0.070 |
Why?
|
Sulfonamides | 1 | 2016 | 1972 | 0.070 |
Why?
|
Stress, Mechanical | 1 | 2010 | 1664 | 0.060 |
Why?
|
Sarcoma | 1 | 2016 | 1784 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11063 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5272 | 0.060 |
Why?
|
Social Class | 1 | 1992 | 1996 | 0.050 |
Why?
|
Microscopy, Fluorescence | 1 | 2010 | 2646 | 0.050 |
Why?
|
Biopsy | 1 | 2015 | 6757 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10749 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11709 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2019 | 4872 | 0.050 |
Why?
|
Orosomucoid | 1 | 2001 | 47 | 0.050 |
Why?
|
Neoplasm Metastasis | 3 | 2016 | 4886 | 0.050 |
Why?
|
Disease Models, Animal | 5 | 2018 | 18114 | 0.050 |
Why?
|
Cesarean Section | 1 | 1989 | 1383 | 0.040 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2023 | 277 | 0.040 |
Why?
|
Fibroblasts | 1 | 2010 | 4087 | 0.040 |
Why?
|
Genome-Wide Association Study | 1 | 2019 | 12601 | 0.040 |
Why?
|
Female | 16 | 2019 | 389943 | 0.040 |
Why?
|
Signal Transduction | 3 | 2018 | 23335 | 0.040 |
Why?
|
RNA Interference | 2 | 2019 | 2834 | 0.040 |
Why?
|
Gold | 1 | 2022 | 479 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13268 | 0.040 |
Why?
|
Mycoplasma hyorhinis | 1 | 2017 | 8 | 0.040 |
Why?
|
Cell Cycle | 2 | 2016 | 2929 | 0.040 |
Why?
|
Gammaproteobacteria | 1 | 2017 | 28 | 0.040 |
Why?
|
Australia | 3 | 1989 | 1235 | 0.040 |
Why?
|
Prognosis | 2 | 2016 | 29488 | 0.040 |
Why?
|
Mitosis | 1 | 2023 | 1186 | 0.040 |
Why?
|
DNA Repair Enzymes | 1 | 2019 | 344 | 0.040 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2020 | 489 | 0.040 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2019 | 412 | 0.040 |
Why?
|
Pregnancy | 8 | 1993 | 29712 | 0.040 |
Why?
|
Chromatography, Gas | 1 | 2016 | 151 | 0.040 |
Why?
|
Receptor, erbB-3 | 1 | 2018 | 143 | 0.040 |
Why?
|
Nitrogen Isotopes | 1 | 2016 | 84 | 0.030 |
Why?
|
Infant Mortality | 2 | 1993 | 757 | 0.030 |
Why?
|
Cell Survival | 2 | 2017 | 5781 | 0.030 |
Why?
|
Mutagenesis | 1 | 2020 | 1233 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 36270 | 0.030 |
Why?
|
Plasmapheresis | 1 | 2016 | 206 | 0.030 |
Why?
|
Integrin alpha5beta1 | 1 | 2016 | 37 | 0.030 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2017 | 256 | 0.030 |
Why?
|
Ipecac | 1 | 1975 | 26 | 0.030 |
Why?
|
Tubulin | 1 | 2019 | 692 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2018 | 11057 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2019 | 64242 | 0.030 |
Why?
|
Protein Binding | 2 | 2019 | 9312 | 0.030 |
Why?
|
Androgens | 1 | 2023 | 1281 | 0.030 |
Why?
|
Accidents, Home | 1 | 1975 | 71 | 0.030 |
Why?
|
First Aid | 1 | 1975 | 67 | 0.030 |
Why?
|
Microscopy, Fluorescence, Multiphoton | 1 | 2016 | 267 | 0.030 |
Why?
|
Extracellular Space | 1 | 2016 | 564 | 0.030 |
Why?
|
Models, Statistical | 1 | 1989 | 5068 | 0.030 |
Why?
|
Hydrazines | 1 | 2016 | 224 | 0.030 |
Why?
|
Anesthetics, Local | 1 | 2001 | 998 | 0.030 |
Why?
|
Delivery, Obstetric | 2 | 1992 | 931 | 0.030 |
Why?
|
Cisplatin | 1 | 2020 | 1647 | 0.030 |
Why?
|
Infant, Newborn | 5 | 1993 | 26176 | 0.030 |
Why?
|
Albumins | 1 | 2016 | 575 | 0.030 |
Why?
|
Hospitals, Special | 1 | 1974 | 91 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2018 | 570 | 0.030 |
Why?
|
Forecasting | 1 | 2023 | 2919 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2018 | 1609 | 0.030 |
Why?
|
Poisoning | 1 | 1975 | 252 | 0.030 |
Why?
|
DNA Replication | 1 | 2020 | 1409 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 2001 | 1897 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2020 | 6128 | 0.030 |
Why?
|
Labor Onset | 1 | 1992 | 17 | 0.030 |
Why?
|
Quinolines | 1 | 2018 | 758 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2016 | 2013 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2018 | 933 | 0.030 |
Why?
|
Fibronectins | 1 | 2016 | 722 | 0.020 |
Why?
|
Mice, SCID | 1 | 2017 | 2625 | 0.020 |
Why?
|
Divorce | 1 | 1992 | 75 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2016 | 1694 | 0.020 |
Why?
|
Mutation | 1 | 2016 | 29929 | 0.020 |
Why?
|
Quinazolines | 1 | 2018 | 1371 | 0.020 |
Why?
|
DNA Repair | 1 | 2020 | 2038 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2018 | 1736 | 0.020 |
Why?
|
Nanoparticles | 1 | 2022 | 1939 | 0.020 |
Why?
|
Marital Status | 1 | 1992 | 426 | 0.020 |
Why?
|
Microtubules | 1 | 2016 | 1073 | 0.020 |
Why?
|
Triazoles | 1 | 2016 | 902 | 0.020 |
Why?
|
DNA Damage | 1 | 2020 | 2439 | 0.020 |
Why?
|
Tumor Burden | 1 | 2016 | 1886 | 0.020 |
Why?
|
Hospitals, Urban | 1 | 1992 | 500 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1477 | 0.020 |
Why?
|
Mental Disorders | 1 | 1989 | 6802 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2017 | 2378 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2018 | 2419 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2017 | 6204 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2016 | 2001 | 0.020 |
Why?
|
Length of Stay | 2 | 1992 | 6384 | 0.020 |
Why?
|
Prenatal Care | 2 | 1992 | 1129 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2019 | 3434 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2796 | 0.020 |
Why?
|
Logistic Models | 2 | 1993 | 13221 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 1992 | 1155 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 1992 | 12047 | 0.020 |
Why?
|
Collagen | 1 | 2016 | 2634 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2018 | 2552 | 0.020 |
Why?
|
Computational Biology | 1 | 2019 | 3501 | 0.020 |
Why?
|
DNA | 1 | 2020 | 7200 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4641 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2020 | 5786 | 0.020 |
Why?
|
Piperazines | 1 | 2016 | 2511 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 2017 | 2522 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6470 | 0.020 |
Why?
|
Random Allocation | 1 | 1989 | 2388 | 0.020 |
Why?
|
Bone Marrow Diseases | 1 | 1966 | 232 | 0.010 |
Why?
|
Urban Population | 1 | 1992 | 2023 | 0.010 |
Why?
|
Intelligence | 1 | 1989 | 921 | 0.010 |
Why?
|
Pyridines | 1 | 2016 | 2864 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1993 | 6230 | 0.010 |
Why?
|
Birth Weight | 1 | 1992 | 2095 | 0.010 |
Why?
|
Gestational Age | 1 | 1992 | 3565 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9403 | 0.010 |
Why?
|
Risk Factors | 4 | 1992 | 73708 | 0.010 |
Why?
|
Adult | 6 | 1993 | 219725 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8503 | 0.010 |
Why?
|
Proteins | 1 | 2016 | 6024 | 0.010 |
Why?
|
Aging | 1 | 2020 | 8654 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2017 | 10405 | 0.010 |
Why?
|
Spectrophotometry | 1 | 2001 | 310 | 0.010 |
Why?
|
Genomics | 1 | 2016 | 5788 | 0.010 |
Why?
|
Male | 4 | 2023 | 358180 | 0.010 |
Why?
|
Binding, Competitive | 1 | 2001 | 1141 | 0.010 |
Why?
|
Odds Ratio | 1 | 1992 | 9624 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 2001 | 683 | 0.010 |
Why?
|
Age Factors | 2 | 1992 | 18326 | 0.010 |
Why?
|
Pediatrics | 1 | 1974 | 3586 | 0.010 |
Why?
|
Sex Factors | 1 | 1993 | 10495 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13463 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 1992 | 7796 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2016 | 9245 | 0.010 |
Why?
|
Liver Diseases | 1 | 1966 | 1296 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 1974 | 7798 | 0.010 |
Why?
|
Child, Preschool | 3 | 1989 | 42045 | 0.010 |
Why?
|
Drug Labeling | 1 | 1975 | 248 | 0.010 |
Why?
|
Infant | 2 | 1989 | 36045 | 0.010 |
Why?
|
Vomiting | 1 | 1975 | 652 | 0.010 |
Why?
|
Family Practice | 1 | 1974 | 509 | 0.010 |
Why?
|
Drug Therapy | 1 | 1974 | 503 | 0.010 |
Why?
|
Organizations | 1 | 1951 | 171 | 0.010 |
Why?
|
Retrospective Studies | 2 | 1989 | 79984 | 0.010 |
Why?
|
Morbidity | 1 | 1974 | 1748 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 1989 | 39020 | 0.000 |
Why?
|
Niemann-Pick Diseases | 1 | 1966 | 27 | 0.000 |
Why?
|
Pigments, Biological | 1 | 1966 | 52 | 0.000 |
Why?
|
Histiocytes | 1 | 1966 | 98 | 0.000 |
Why?
|
Research Design | 1 | 2001 | 6152 | 0.000 |
Why?
|
Drug Prescriptions | 1 | 1974 | 1666 | 0.000 |
Why?
|
Residence Characteristics | 1 | 1974 | 2058 | 0.000 |
Why?
|
Time Factors | 2 | 1975 | 39811 | 0.000 |
Why?
|
Referral and Consultation | 1 | 1974 | 3579 | 0.000 |
Why?
|
Child | 3 | 1975 | 79782 | 0.000 |
Why?
|
Diarrhea | 1 | 1966 | 1317 | 0.000 |
Why?
|
Respiratory Tract Infections | 1 | 1966 | 1004 | 0.000 |
Why?
|
Hospitalization | 1 | 1974 | 10634 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1966 | 12951 | 0.000 |
Why?
|
Adolescent | 1 | 1974 | 87819 | 0.000 |
Why?
|